Quarter Financials

Relmada Therapeutics, Inc. (RLMD)

$3.01

+0.01 (+0.33%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands , Years are calendar years not fiscal years

Retained Earning Schedule

Year 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3
Net Income -25-24-37-40-34-41-34-43
Dividend Paid --------
Retained Earnings -514-488-462-424-385-345-305-271

PPE Schedule

Year 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3
Capital Expenditure --------
Net PPE --------

Intangible and Goodwill Schedule

Year 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3
New Purchases -26-141-26-7-6-8-35-11
Intangible and Goodwill --------